Zirabev
NDC 0069-0315 · Pfizer Laboratories Div Pfizer Inc
Generic namebevacizumab-bvzr
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)BEVACIZUMAB
Strength100 mg/4mL
Pharmacologic classVascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
Marketing categoryBLA
Packages
0069-0315-01 — 1 VIAL, SINGLE-USE in 1 CARTON (0069-0315-01) / 4 mL in 1 VIAL, SINGLE-USE
Billed under HCPCS
Q5118 — Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg Medicare Part B payment limit (ASP + 6%): $25.89
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0069-0342 — bevacizumab-bvzr, 50242-060 — bevacizumab, 50242-061 — bevacizumab, 55513-206 — bevacizumab-awwb, 55513-207 — bevacizumab-awwb, 70121-1754 — bevacizumab-maly, 70121-1755 — bevacizumab-maly, 72606-011 — bevacizumab-adcd, 72606-012 — bevacizumab-adcd, 82491-025 — bevacizumab-vikg, 83257-009 — bevacizumab-nwgd, 83257-010 — bevacizumab-nwgd